Search Immortality Topics:


11th European and Global Summit for Clinical Nanomedicine …

Posted: November 9, 2018 at 1:42 pm

CLINAM FoundationThe goal of the CLINAM Foundation is to contribute to the benefit of patients and society by exploring and translating leading edge technologies towards clinical application, with an emphasis on nanomedicine, targeted medicine, precision medicine and personalization. The summit keeps its tradition to build bridges from the enabling technologies to clinical application for major and neglected diseases. There is broad support for this summit by many collaborating institutions.

Scientific Committee Prof. Dr. med. Patrick Hunziker, University Hospital Basel (CH) (chairman) Prof. Dr. med. Christoph Alexiou, Head, Section of Experimental Oncology and Nanomedicine (SEON),Else Krner-Fresenius-Foundation Professorship, University Hospital Erlangen (D) Prof. Dr. Lajos Balogh, Editor-in-Chief, Precision Nanomedicine Journal, North Andover, MA (USA) Prof. Dr. Gerd Binnig, Nobel Laureate, Munich (D) Prof. Dr. Yechezkel Barenholz, Hebrew University, Hadassah Medical School, Jerusalem (IL) Prof. Dr. med. Omid Farokhzad, Director, Center for Nanomedicine, Harvard Medical Schooland Brigham and Women's Hospital, Boston, MA (USA) Prof. Dr. Twan Lammers, Experimental Molecular Imaging, RWTH Aachen (D) Prof. Dr. med. Dong Soo Lee, PhD, Chair, Department of Nuclear Medicine, Seoul NationalUniversity, Seoul (KOR) Dr. med. h.c. Beat Lffler, MA, CEO, CLINAM-Foundation, Basel (CH) (contents and programme) Prof. Dr. med. Marisa Papaluca, European Medicines Agency (EMA), London (UK) Prof. Dr. Gert Storm, Institute for Pharmaceutical Sciences, Utrecht University, Utrecht (NL) Prof. Dr. Dr. h.c. Viola Vogel, Head, Department of Health Sciences and Technology Laboratory of Applied Mechanobiology, ETH Zrich (CH)

IntroductionThe CLINAM Summit is a globally unique event that brings together all stakeholders in nanomedicine, targeted medicine and precision medicine. It builds on the principle that fundamental scientists, developers and profes-sionals in clinical application and all to nanomedicine related persons can mutually learn from each other to find better solutions for the medicine of the future. Based on recent groundbreaking achievements, the meeting will be a highlight to explore the pathways to personalized medicine and highlight its potential for prevention, diagnosis, therapy by development of tools, materials and strategies for this young field. CLINAM is thus evolving toward its role as the international meeting forum for interdisciplinary fields of cutting edge medicine. CLINAM will again welcome the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine. Senior scientists enlighten young researchers and students with their long experience and expertise. The summit expects again about 500 participants from more than 35 countries that make use of the role of the CLINAM Foundation as the nonprofit service provider for novel nanomedicine, targeted delivery and precision medicine. CLINAM BASEL welcomes you and wishes you three days of great science, great contacts and high level wellbeing with cultural elements in the evenings.CLINAM is the worldwide melting pot in the field of nanomedicine, targeted delivery and precision medicine. Meet in Basel at a high-level communication platform where you find those striving for the development in all fields of renewing medicine.

Target AudienceThe faculty includes the pioneers and opinion leaders in the fields of medicine, nanoscience and targeted medicine, who share experience in an interdisciplinary and interactive manner that widens mutual understanding for both sides. The summit and the exhibition are aimed at physicians, as well as nonscientists with a background in pharmacology, biology, physics, chemistry, biophysics, medicine, materials science and engineering. The meeting is a particularly useful source of knowledge for the targeted medicine and delivery community. The conference is also of interest for members of the regulatory authorities as well as policymakers, experts from industry in the field of life sciences, developers of new tools and materials for nanomedicine, and all those investigating the potential of emerging technologies in the field of healthcare. Experts from venture companies can acquire knowledge on existing and upcoming developments and novel products in the emerging field of nanomedicine and knowledge based medicine. Government authorities can profit from the regulators international sessions.Visa for Switzerland Embassy Appointment minimum 6 weeks before travelling!Before registering, check Visa-Regulations for Switzerland: Participants with visa-need for entering Switzerland have to make their appointment with the Swiss Embassy 6 weeks before the Summit in their country in order to make an application and to acquire a visa. All concerned will ask us in a mail to send an official invitation letter, which you will have to present at the embassy. For this we need your statement of nationality, full address, periapt address, passport number, date of birth.

Registration for the Summit: clinam18.viva-events.ch

CLINAM Exhibition:Profit of ExhibitingExhibitors at the CLINAM Summit profit from meeting their potential clients in one spot since CLINAM is presently the worlds largest summit on Clinical Nanomedicine with 500+ participants in need of toolmakers findings, knowledge and their devices. SMEs and small Start-up companies have the chance to showcase their skills at an affordable price and to meet ALL STAKEHOLDERS in the field of nanomedicine, targeted delivery and precision medicine. This is a Foyer exhibition at low exhibitors rate. All breaks and catering for lunches take place in midst of the CLINAM marketplace. Start-up booths are given to companies that are less than 3 years in active development.

Regular Fees Booking online: clinam18.viva-events.chFloor Space (350 /m2) 6 m2 2'100.00 (minimum)8 m2 2'800.00 12 m2 4000.00 (Maximum is 36 m2) Company name A3 on pillar 100 1 table, 2 chairs, 1 pin board for poster & power connection 200 Exhibitors Ticket for Conference Exhibitors multi-user-badge 800 Booth Construction on demand

Special Start-up Booth4 m2, 1 table, 2 chairs, pillar, power connection, 1 pin board and 1 registration(Upon application, company less than 3 years active) 1650.00

Summit VenueCongress Center Basel Messeplatz 21 CH-4021 Basel, Switzerland Phone +41 58 206 28 28This email address is being protected from spambots. You need JavaScript enabled to view it.

Registration OfficeViva Management GmbH Kramgasse 16C -3011 Bern, Switzerland Phone +41 31 311 74 34This email address is being protected from spambots. You need JavaScript enabled to view it.

Organizers Oce European Foundation forClinical Nanomedicine (CLINAM) Alemannengasse 12CH-4058 Basel, Switzerland Phone +41 61 695 93 95This email address is being protected from spambots. You need JavaScript enabled to view it.

Exhibitors at CLINAM 11/2018 (Status June) Izon Science Europe Ltd. Nacamed Resistell AG Precision Nanomedicine PRNANO Deutsche Plattform Nano Biomedizin Particle Metrix GmbH SiBreaX AG Precision NanoSystems, Inc. Polymun Scientific GmbH Lipoid AG Seroscience Ltd. InnoMedica AG ESNAM, edinethics TECOmedical AG Aseptic Technologies S.A. EVA - the Basel Life Sciences Start-up Agency/BASEL INKUBATOR CIBER-BBN Cordouan Technologies

Sponsors of the 11th European and Global Summit for Clinical Nanomedicine, Targeted Delivery and Precision Medicine The Building Blocks to Personalized Medicine

The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. Aiming at prevention, diagnosis, and therapy through nanomedicine as well as at exploration of its implications, the Foundation reaches its goals through support of clinically focussed research and of interaction and information flow between clinicians, researchers, the public, and other stakeholders. The recognition of the large future impact of nanoscience on medicine and the observed rapid advance of medical applications of nanoscience have been the main reasons for the creation of the Foundation.Nanotechnology for MedicineNanotechnology is generally considered as the key technology of the 21st century. It is an interdisciplinary scientific field focusing on methods, materials, and tools on the nanometer scale, i.e. one millionth of a millimeter. The application of this science to medicine seeks to benefit patients by providing prevention, early diagnosis, and effective treatment for prevalent, for disabling, and for currently incurable medical conditions.

See the original post:
11th European and Global Summit for Clinical Nanomedicine ...

Recommendation and review posted by G. Smith